The facility will cater to patients with aggressive blood cancers, including leukaemias, lymphomas, and other cancers. Credit: Radowitz / Shutterstock.

Tampa General Hospital (TGH) in the US has launched a new outpatient transplant unit at the TGH Cancer Institute to offer alternative cell therapy treatment.

The new cellular-immunotherapy transplant unit (CTU) will provide treatment options for patients with aggressive blood cancers, such as lymphomas, leukaemias, multiple myeloma, and other cancers.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

TGH Cancer Institute vice-president and executive director Dr Eduardo Sotomayor said: “The establishment of the new cellular-immunotherapy transplant unit at the TGH Cancer Institute represents a major milestone in our endeavour to remain at the forefront of innovative treatments for patients with complex cancers.

“Through this latest advancement, patients can receive cell therapy treatment at Tampa General on an outpatient, instead of inpatient, basis.”

Adults receiving chimeric antigen receptor (CAR) T-cell therapy and bone marrow transplant (BMT) will receive daily treatment as outpatients at the new unit.

They can receive the treatment while residing at home, provided that they have a 24/7 caregiver to track their condition, take vitals, and maintain regular communication with TGH clinicians.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Patients and their caregivers must satisfy specific medical criteria, reside within the hospital’s 60-minute radius, and take a compulsory educational course to be eligible for the outpatient treatment programme.

Tampa General multiple myeloma, BMT and cell therapies programme director Dr Ivan Borrello is leading the CTU with support from a team of nurses, practitioners, and social workers specialising in cell therapy.

The care team conducts thorough evaluations of CTU patients to determine whether outpatient cell therapy is the most suitable treatment option.

The CTU team ensures quick hospital admission if a patient’s condition necessitates it.

Designed for patient comfort, the TGH Cancer Institute cell therapy unit offers beds or recliners during treatment sessions.

Supported by academic medicine, the institute delivers care through therapies, diagnostic imaging tools, and a coordinated approach to patient care.